The Biden administration moved Friday to negotiate the prices Medicare pays for the blockbuster weight-loss drugs Ozempic and Wegovy, medications costing the massive government health program ...

A novel medication out of Sweden has shown some of the same promise in melting belly fat — without making your stomach churn.

A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Medicare will seek to negotiate lower list prices for the blockbuster diabetes and weight loss drugs Ozempic and Wegovy and 14 other medications, a cost-saving move that would take effect in 2027.

Medicare Part D covers Ozempic, but the drug is not prescribed solely for weight loss. Patients using the drug for that purpose would have to pay for the injections out of pocket. Novo Nordisk’s ...

Millions of Americans with obesity would be eligible to have popular weight-loss drugs like Wegovy or Ozempic covered by Medicare or Medicaid under a new rule the Biden administration proposed ...

Medicare’s prices for the blockbuster weight-loss drugs Ozempic and Wegovy are likely to decline starting in 2027, thanks to their inclusion on a list of medicines whose prices will be ...

Weight loss drugs like Ozempic may be up for Medicare price negotiations — will Trump support it? The list of 15 more of the priciest medications selected for the negotiation program is supposed ...

Expanding Medicare to cover weight loss drugs would cost $35 billion over eight years, according to a new report from the Congressional Budget Office (CBO). In its estimates released Tuesday, CBO ...

News; Nation/World; Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs Jan. 17, 2025 Updated Fri., Jan. 17, 2025 at 10:17 p.m. Senate Health, Education, Labor, and Pensions Committee ...

Medicare to negotiate price of Ozempic, Wegovy weight-loss drugs Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs. Updated January 17, 2025 ...